Evidence map›Paper›PMID 42057211›Full record

ReviewBiotechnology for biofuels and bioproducts2026

Advances, challenges, and future directions towards a cellulolytic Escherichia coli.

Eliseo R Molina-Vázquez, Ricardo Oropeza, Alfredo Martinez

Abstract readReview
In one paragraph

Review in Biotechnology for biofuels and bioproducts, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eliseo R Molina-VázquezDepartment of Cellular Engineering and Biocatalyst, Instituto de Biotecnología, Universidad Nacional Autónoma de México. Av. Universidad, 2001, Col. Chamilpa, 62210, Cuernavaca, Morelos, México.ORCID http://orcid.org/0009-0002-4021-7936
Ricardo OropezaDepartment of Molecular Microbiology, Instituto de Biotecnología, Universidad Nacional Autónoma de México. Av. Universidad, 2001, Col. Chamilpa, 62210, Cuernavaca, Morelos, México.ORCID http://orcid.org/0000-0002-6765-213X
Alfredo MartinezDepartment of Cellular Engineering and Biocatalyst, Instituto de Biotecnología, Universidad Nacional Autónoma de México. Av. Universidad, 2001, Col. Chamilpa, 62210, Cuernavaca, Morelos, México. alfredo.martinez@ibt.unam.mx.ORCID http://orcid.org/0000-0002-4804-6687

Funding

SECIHTI - Mexico CF-2023-I-1116
6 · The paper itself

Abstract

backgroundEscherichia coli has been widely engineered as a microbial chassis for the biosynthesis of a broad spectrum of products ranging from basic building blocks and biocommodities to high-value fine chemicals and drugs. However, most current bioprocesses still rely on conventional feedstocks such as corn-derived glucose and sugarcane-derived sucrose, which are also demanded by established food and industrial supply chains. Consequently, allocating these sugars to the production of biocommodities, which are required in large quantities and at low cost, may exacerbate concerns about food security and undermine the long-term sustainability of large-scale biomanufacturing relative to low-cost petrochemical routes, particularly for bulk chemicals. MAIN TEXT: Lignocellulosic biomass, derived from agricultural residues and urban waste, presents a low-cost, renewable, and abundant alternative source of fermentable sugars. Composed of an intricate matrix of cellulose, hemicellulose, and lignin, lignocellulose exhibits a high degree of structural recalcitrance. To access its fermentable components, biomass typically needs physicochemical pretreatment and enzymatic saccharification using commercial cellulases. Unfortunately, these enzymes are expensive, and their optimal catalytic properties are typically achieved under conditions incompatible with those required by conventional E. coli production strains, thereby complicating the integration of saccharification and fermentation processes. To overcome this barrier, significant efforts have been made to engineer recombinant cellulolytic E. coli strains capable of degrading cellulose. Strategies explored include intracellular expression of cellulases followed by induced lysis, enzyme secretion via signal peptides, and surface display of cellulolytic enzymes, among others.

conclusionsKey advances toward achieving saccharolytic E. coli have been achieved. Proof-of-concept studies have demonstrated simultaneous saccharification and fermentation using pretreated lignocellulosic biomass, and high-throughput platforms for evolving cellulolytic enzymes have been established. Despite substantial progress, knowledge in this field remains fragmented across diverse studies. This review consolidates key advancements in the development of cellulolytic E. coli strains, emphasizing the molecular, metabolic, and physiological engineering strategies employed. It also highlights key challenges and future directions for integrating lignocellulose utilization into industrial E. coli-based bioprocesses.

Indexed as

CellobiohydrolasesCell surface displayCelluloseConsolidated bioprocessesEndoglucanasesEscherichia coliExtracellular secretionLignocelluloseMetabolic engineeringβ-Glucosidases

Identifiers

PMID42057211
PMCPMC13267602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.